Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 2
2008 1
2012 1
2013 1
2015 1
2018 1
2019 1
2020 1
2021 1
2022 2
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS.
Miller TM, Cudkowicz ME, Genge A, Shaw PJ, Sobue G, Bucelli RC, Chiò A, Van Damme P, Ludolph AC, Glass JD, Andrews JA, Babu S, Benatar M, McDermott CJ, Cochrane T, Chary S, Chew S, Zhu H, Wu F, Nestorov I, Graham D, Sun P, McNeill M, Fanning L, Ferguson TA, Fradette S; VALOR and OLE Working Group. Miller TM, et al. N Engl J Med. 2022 Sep 22;387(12):1099-1110. doi: 10.1056/NEJMoa2204705. N Engl J Med. 2022. PMID: 36129998 Free article. Clinical Trial.
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study.
Bril V, Drużdż A, Grosskreutz J, Habib AA, Mantegazza R, Sacconi S, Utsugisawa K, Vissing J, Vu T, Boehnlein M, Bozorg A, Gayfieva M, Greve B, Woltering F, Kaminski HJ; MG0003 study team. Bril V, et al. Lancet Neurol. 2023 May;22(5):383-394. doi: 10.1016/S1474-4422(23)00077-7. Lancet Neurol. 2023. PMID: 37059507 Clinical Trial.
Efficacy of l-Arginine treatment in patients with HTLV-1-associated neurological disease.
Nozuma S, Matsuura E, Tashiro Y, Nagata R, Ando M, Hiramatsu Y, Higuchi Y, Sakiyama Y, Hashiguchi A, Michizono K, Higashi K, Matsuzaki T, Kodama D, Tanaka M, Yamano Y, Moritoyo T, Kubota R, Takashima H. Nozuma S, et al. Among authors: higashi k. Ann Clin Transl Neurol. 2023 Feb;10(2):237-245. doi: 10.1002/acn3.51715. Epub 2022 Dec 22. Ann Clin Transl Neurol. 2023. PMID: 36547017 Free PMC article. Clinical Trial.
Anti-ganglionic acetylcholine receptor antibodies in functional neurological symptom disorder/conversion disorder.
Nagata R, Matsuura E, Nozuma S, Dozono M, Noguchi Y, Ando M, Hiramatsu Y, Kodama D, Tanaka M, Kubota R, Yamakuchi M, Higuchi Y, Sakiyama Y, Arata H, Higashi K, Hashiguchi T, Nakane S, Takashima H. Nagata R, et al. Among authors: higashi k. Front Neurol. 2023 Feb 13;14:1137958. doi: 10.3389/fneur.2023.1137958. eCollection 2023. Front Neurol. 2023. PMID: 36860574 Free PMC article.
Cryptococcus Meningitis Can Co-occur with Anti-NMDA Receptor Encephalitis.
Sakiyama Y, Matsuura E, Shigehisa A, Hamada Y, Dozono M, Nozuma S, Nakamura T, Higashi K, Hashiguchi A, Takahashi Y, Takashima H. Sakiyama Y, et al. Among authors: higashi k. Intern Med. 2020 Sep 15;59(18):2301-2306. doi: 10.2169/internalmedicine.4629-20. Epub 2020 Jun 9. Intern Med. 2020. PMID: 32522922 Free PMC article.
New type of encephalomyelitis responsive to trimethoprim/sulfamethoxazole treatment in Japan.
Sakiyama Y, Kanda N, Higuchi Y, Yoshimura M, Wakaguri H, Takata Y, Watanabe O, Yuan J, Tashiro Y, Saigo R, Nozuma S, Yoshimura A, Arishima S, Ikeda K, Shinohara K, Arata H, Michizono K, Higashi K, Hashiguchi A, Okamoto Y, Hirano R, Shiraishi T, Matsuura E, Okubo R, Higuchi I, Goto M, Hirano H, Sano A, Iwasaki T, Matsuda F, Izumo S, Takashima H. Sakiyama Y, et al. Among authors: higashi k. Neurol Neuroimmunol Neuroinflamm. 2015 Aug 13;2(5):e143. doi: 10.1212/NXI.0000000000000143. eCollection 2015 Oct. Neurol Neuroimmunol Neuroinflamm. 2015. PMID: 26309903 Free PMC article.
14 results